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Introduction 
The rheological properties of joint fluid (SF) can be attributed to the presence within this medium of 
high concentrations (-3mg/ml) of hyaluronan ~(HA), a linear glycosaminoglycan synthesised by 
synoviocytes ofthe joint lining. In osteoarthritis (OA) the concentration and molecular size of HA in SF may 
be reduced [1] because of plasma fluid infiltration, abnormal synoviocyte metabolism or depolymerisation 
by oxygen-derived free radicals. Such processes can result in a diminution in SF viscosity leading to a decline 
in its ability to protect and lubricate articular cartilage and adjacent structures as well as bind inflammatory 
mediators and phospholipids. In a previous tudy using synoviocytes from joints of OA and RA patients, we 
showed that the drug pentosan polysulphate (PPS) stimulated the synthesis of high molecular weight 
(MW)-HA at low ( < 5 gg/ml) in v i t roconcentrat ions  [2]. This was confirmed in vivo by Verbruggen and Veys 
[3] who reported that 2-6 intra-articular (i.a.) injections of pentosan PPS (50 #rag) into joints of rheumatoid 
patients increase the MW of their SF-HA by a median value of 69%. 
Objectives 
The objectives of the present study was to determine ifi.a. PPS therapy increased the MW of HA and improved 
the visco-elasticity of SF from joints of patients with OA. 
Methods 
SFs were aspirated, where possible, from "blinded" OA patients (n = 23) before and after 4 weekly i.a. 
injections of either PPS (1 ml, 50 rag) (n = 13) or Ringer's olution (placebo) (1 ml) (n = 10). Cells were removed 
by centrifugation and supernatants stored frozen. The viscosity (7 9 and elastic stiffness (G') of undiluted SFs 
were determined as a function of angular frequency using a unique micro-Fourier rheometer developed by 
one of the investigators (MS). The molecular weight distribution of SF-HA was evaluated by gel-permeation 
chromatography/multi/angle laser-light scattering (GPC-MALLS) using diluted SFs. 
Results 
For the present report the rheological parameters for SF from placebo- and PPS-treated groups were 
determined for an instrument frequency of 10 Hz. This value corresponds to62.8 radians/sec, which simulates 
joint articulation during walking. The mean % change ( _ SEM) in the SF rheological index (a function 
combing 7' and G') for the PPS group before, and after i.a. treatment, was 58.4_ 19.2% while the 
corresponding placebo group value was 12.1 __ 9.3%. The improvement in the theological index for PPS-SF 
compared to placebo values was statistically significant (p = 0.044). The MW of SF-HA was also elevated in 
the PPS group compared to placebo SF-HA (p < 0.05). 
Conclusion 
Four i.a. injections of PPS (50 rag) markedly increase SF-HA molecular weight and rheological indices. We 
suggest hat this improvement in "quality" of SF contributes to the restoration of joint function in OA 
patients. 
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